Shilpa Lingala

Statistics

Publications

Citations

1.2K

H-Index

Active since

2010

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

National Institutes of Health

National Heart Lung and Blood Institute

University of California Davis Medical Center

National Cancer Institute

Shilpa Lingala is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in medicine, liver disease, and hepatology.

Publications per year

2010–2020

Publications

Danazol Treatment for Telomere Diseases

Danielle M. Townsley, Bogdan Dumitriu, Delong Liu et al. · New England Journal of Medicine · 2016 · 402 citations · Full text

Medicine, Endocrinology, Hematology +17

Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations

Xiaoli Chen, Shilpa Lingala, Shiva Khoobyari et al. · Journal of Hepatology · 2011 · 209 citations · Full text

Medicine, Cancer Biology, Oncology +14

Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation

Christina Lam, Carlos R. Ferreira, Donna M. Krasnewich et al. · Genetics in Medicine · 2016 · 147 citations · Full text

Life Sciences, Genetics, Molecular Medicine +12

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma

Shilpa Lingala, Yiyao Cui, Xiaoli Chen et al. · Experimental and Molecular Pathology · 2010 · 112 citations · Full text

Medicine, Cell Biology, Oncology +16

Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis

Maren C. Podszun, Ahmad S. Alawad, Shilpa Lingala et al. · Redox Biology · 2020 · 110 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

1–5 of 10